Valuation Gedeon Richter OTC Markets

Stocks

GEDSF

US3684672054

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 12:42:15 29/07/2025 am IST			5-day change	1st Jan Change
30.92 ^USD	+24.45%		-.--%	-

16/06	AI in Hungary could unlock productivity gains of EUR15 billion, McKinsey says	RE
10/06	Gedeon Richter Plc. and Hetero Labs Ltd. Announce Global Collaboration Agreement for Joint Development, Registration, and Commercialization of Semaglutide Injection	CI

Company Valuation: Gedeon Richter

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	16,19,625	15,42,290	16,27,029	18,93,161	17,99,226	22,23,308	-	-
Change	-	-4.77%	5.49%	16.36%	-4.96%	23.57%	-	-
Enterprise Value (EV) ¹	15,59,769	13,95,557	15,46,536	17,82,343	15,88,618	19,08,718	18,01,918	16,83,303
Change	-	-10.53%	10.82%	15.25%	-10.87%	20.15%	-5.6%	-6.58%
P/E	11.6x	9.94x	10.2x	7.96x	7.76x	8.51x	7.81x	7.13x
PBR	1.78x	1.47x	1.44x	1.49x	1.31x	1.47x	1.33x	1.21x
PEG	-	0.9x	3.41x	0.2x	-2.82x	0.7x	0.87x	0.75x
Capitalization / Revenue	2.57x	1.92x	2.02x	2.21x	1.94x	2.34x	2.17x	2.02x
EV / Revenue	2.47x	1.74x	1.92x	2.08x	1.71x	2.01x	1.76x	1.53x
EV / EBITDA	8.86x	7.1x	6.43x	5.74x	4.5x	5.25x	4.62x	3.97x
EV / EBIT	11.5x	9.09x	8.15x	6.82x	5.42x	6.36x	5.51x	4.78x
EV / FCF	-460x	12.3x	17.9x	8.26x	7.56x	8.98x	7.79x	6.69x
FCF Yield	-0.22%	8.12%	5.6%	12.1%	13.2%	11.1%	12.8%	14.9%
Dividend per Share ²	225	390	-	-	-	620.6	664.4	733
Rate of return	2.58%	4.7%	-	-	-	5.09%	5.45%	6.01%
EPS ²	751	835	860	1,307	1,271	1,432	1,561	1,709
Distribution rate	30%	46.7%	-	-	-	43.3%	42.6%	42.9%
Net sales ¹	6,30,595	8,02,755	8,05,158	8,57,545	9,28,962	9,51,724	10,23,546	10,98,192
EBITDA ¹	1,76,123	1,96,480	2,40,625	3,10,678	3,53,314	3,63,366	3,89,794	4,24,113
EBIT ¹	1,35,832	1,53,555	1,89,817	2,61,157	2,92,851	2,99,996	3,26,732	3,51,898
Net income ¹	1,39,626	1,55,581	1,58,850	2,39,244	2,32,335	2,59,474	2,86,154	3,13,070
Net Debt ¹	-59,856	-1,46,733	-80,493	-1,10,818	-2,10,608	-3,14,590	-4,21,390	-5,40,005
Reference price ²	8,725.00	8,300.00	8,750.00	10,400.00	9,865.00	12,190.00	12,190.00	12,190.00
Nbr of stocks (in thousands)	1,85,630	1,85,818	1,85,946	1,82,035	1,82,385	1,82,388	-	-
Announcement Date	02/03/22	28/02/23	29/02/24	07/04/25	27/02/26	-	-	-

¹HUF in Million²HUF

Estimates

P/E, Detailed evolution

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	39.29x	7.46x	25.43x	0.79%	4.8TCr
OTSUKA HOLDINGS CO., LTD.	18.78x	2.12x	10.01x	1.29%	3.69TCr
CIPLA LIMITED	28.07x	3.47x	17.79x	0.86%	1.24TCr
ZYDUS LIFESCIENCES LIMITED	25.01x	4.33x	16.13x	0.71%	1.19TCr
KRKA, D. D.	19.52x	3.37x	12.24x	3.5%	901.14Cr
ONO PHARMACEUTICAL CO., LTD.	16.15x	2.07x	6.97x	3.24%	704.81Cr
GLENMARK PHARMACEUTICALS LIMITED	33.56x	3.82x	16.25x	0.24%	655.31Cr
AJANTA PHARMA LIMITED	39.67x	7.59x	28.17x	1%	436.29Cr
Average	27.51x	4.28x	16.62x	1.45%	1.7TCr
Weighted average by Cap.	28.69x	4.66x	17.56x	1.21%